Newswise Focus Channel: Coronavirus Channel Featured Story TOP /articles/channels/Coronavirus Channel Featured Story TOP This [feature]/[breaking news]/[focus] channel highlights experts, research, and feature stories related to... en-us Copyright 2024 Newswise Newswise Focus Channel: Coronavirus Channel Featured Story TOP 115 31 / /images/newswise-logo-rss.gif Scientists discover how ultraviolet light degrades coronavirus /articles/scientists-discover-how-ultraviolet-light-degrades-coronavirus/?sc=c6547 /articles/scientists-discover-how-ultraviolet-light-degrades-coronavirus/?sc=c6547 Wed, 10 Jan 2024 13:05:07 EST Healthcare,Infectious Diseases,Public Health,Coronavirus,All Journal News,Top Hit Stories Medical News,Science News Research Results New research has revealed how light can be used to destroy infectious coronavirus particles that contaminate surfaces. University of Southampton Key Change in Genetics of SARS-CoV-2 Evolved to Counter Weakness Caused by the Virus' Initial Mutation that Enabled Its Spread /articles/key-change-in-genetics-of-sars-cov-2-evolved-to-counter-weakness-caused-by-the-virus-initial-mutation-that-enabled-its-spread/?sc=c6547 /articles/key-change-in-genetics-of-sars-cov-2-evolved-to-counter-weakness-caused-by-the-virus-initial-mutation-that-enabled-its-spread/?sc=c6547 Thu, 12 Jan 2023 09:00:31 EST All Journal News,Infectious Diseases,Coronavirus,Genetics,Public Health,Staff Picks,Cell Biology,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2023/01/11/63bf06d9ba85e_GettyImages-1209688759.jpg&width=100&height=150" alt="Newswise image" />Researchers at Johns Hopkins Medicine say their new studies suggest that the first pandemic-accelerating mutation in the SARS-CoV-2 virus, which causes COVID-19, evolved as a way to correct vulnerabilities caused by the mutation that started the SARS-CoV-2 pandemic. /articles//images/uploads/2023/01/11/63bf06d9ba85e_GettyImages-1209688759.jpg Johns Hopkins Medicine COVID-19 vaccine's effectiveness diminishes with age, research shows /articles/covid-19-vaccine-s-effectiveness-diminishes-with-age-research-shows/?sc=c6547 /articles/covid-19-vaccine-s-effectiveness-diminishes-with-age-research-shows/?sc=c6547 Tue, 29 Nov 2022 16:00:24 EST Healthspan,All Journal News,Infectious Diseases,Public Health,Vaccines,Coronavirus,Cell (journal),Top Hit Stories,Staff Picks Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/11/29/638660ac788a0_DrLenetteLu07092021IM6412.jpg&width=100&height=150" alt="Newswise image" />The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers. /articles//images/uploads/2022/11/29/638660ac788a0_DrLenetteLu07092021IM6412.jpg UT Southwestern Medical Center Investigating COVID-19 deaths for children and young people /articles/investigating-covid-19-deaths-for-children-and-young-people/?sc=c6547 /articles/investigating-covid-19-deaths-for-children-and-young-people/?sc=c6547 Tue, 08 Nov 2022 14:00:00 EST Children's Health,Healthcare,Infectious Diseases,Public Health,Vaccines,Coronavirus,PLOS,All Journal News Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/11/02/6362cada17501_unnamed6.jpg&width=100&height=150" alt="Newswise image" />A new study conducted in England shows that the risk of death due to COVID-19 remains very low for children and young people, and most deaths occur in those with underlying health conditions. Marta Bertran of the UK Health Security Agency, London, and colleagues present these findings on November 8th in the open access journal PLOS Medicine. /articles//images/uploads/2022/11/02/6362cada17501_unnamed6.jpg PLOS How a SARS-CoV-2 Virus Protein Damages the Heart /articles/how-a-sars-cov-2-virus-protein-damages-the-heart/?sc=c6547 /articles/how-a-sars-cov-2-virus-protein-damages-the-heart/?sc=c6547 Mon, 07 Nov 2022 19:05:59 EST All Journal News,Cardiovascular Health,Healthcare,Heart Disease,Public Health,Coronavirus,Top Hit Stories,Staff Picks,Top Clipped Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/11/07/63699b910b24c_Nspheartcropped.jpg&width=100&height=150" alt="Newswise image" />Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart. /articles//images/uploads/2022/11/07/63699b910b24c_Nspheartcropped.jpg University of Maryland School of Medicine Treated or Not, COVID-19 Recurrence Seems Symptomatic for Some /articles/treated-or-not-covid-19-recurrence-seems-symptomatic-for-some/?sc=c6547 /articles/treated-or-not-covid-19-recurrence-seems-symptomatic-for-some/?sc=c6547 Mon, 31 Oct 2022 12:10:10 EST Infectious Diseases,Pharmaceuticals,Public Health,Coronavirus,JAMA,All Journal News,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/10/31/635fe57738037_daveysmith-afar-400px.jpg&width=100&height=150" alt="Newswise image" />UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms. /articles//images/uploads/2022/10/31/635fe57738037_daveysmith-afar-400px.jpg,/images/uploads/2022/10/31/635fe57bed3cd_sem-covid-niaid-400px.jpg University of California San Diego Penn State scientists one step closer to adaptation-proof COVID-19 vaccine /articles/penn-state-scientists-one-step-closer-to-adaptation-proof-covid-19-vaccine/?sc=c6547 /articles/penn-state-scientists-one-step-closer-to-adaptation-proof-covid-19-vaccine/?sc=c6547 Tue, 18 Oct 2022 10:05:43 EST All Journal News,Immunology,Infectious Diseases,Vaccines,Coronavirus,Staff Picks,Top Clipped Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/10/18/634ebb2ec58ef_Dokholyanimagesized.jpg&width=100&height=150" alt="Newswise image" />A vaccine that could protect against new variants of SARS-CoV-2 and also potentially protect against other coronaviruses is one step closer to reality thanks to College of Medicine researchers. /articles//images/uploads/2022/10/18/634ebb2ec58ef_Dokholyanimagesized.jpg Penn State College of Medicine Other SARS-CoV-2 Proteins are Important for Disease Severity, Aside from the Spike /articles/other-sars-cov-2-proteins-are-important-for-disease-severity-aside-from-the-spike/?sc=c6547 /articles/other-sars-cov-2-proteins-are-important-for-disease-severity-aside-from-the-spike/?sc=c6547 Mon, 10 Oct 2022 07:05:02 EST All Journal News,Genetics,Immunology,Infectious Diseases,Vaccines,Coronavirus,Staff Picks,Grant Funded News,PNAS,Top Hit Stories Medical News Research Results University of Maryland School of Medicine researchers have identified how multiple genes of SARS-CoV-2 affect disease severity, which could lead to new ways in how we develop future vaccines or develop newer treatments. The genes control the immune system of the host, contributing to how fiercely the body responds to a COVID-19 infection. University of Maryland School of Medicine Vaccines dramatically reduce the risk of long-term effects of COVID-19 /articles/vaccines-dramatically-reduce-the-risk-of-long-term-effects-of-covid-19/?sc=c6547 /articles/vaccines-dramatically-reduce-the-risk-of-long-term-effects-of-covid-19/?sc=c6547 Thu, 08 Sep 2022 04:00:00 EST All Journal News,Infectious Diseases,Public Health,Vaccines,Coronavirus Medical News Research Results Being vaccinated with at least two doses of Pfizer vaccines dramatically reduces most of the long-term symptoms individuals reported months after contracting COVID-19, a new study shows. Bar-Ilan University New Data Shows COVID-19 Vaccine Does Not Raise Stroke Risk /articles/new-data-shows-covid-19-vaccine-does-not-raise-stroke-risk/?sc=c6547 /articles/new-data-shows-covid-19-vaccine-does-not-raise-stroke-risk/?sc=c6547 Wed, 24 Aug 2022 17:00:48 EST Cardiovascular Health,Infectious Diseases,Neuro,Public Health,Vaccines,Coronavirus,Neurology (journal),All Journal News Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/08/24/6306900f47e78_1920vaccine-covid-stroke-cedars-sinai.jpg&width=100&height=150" alt="Newswise image" />Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does. Physician-scientists hope this growing body of evidence, highlighted today in an editorial in the peer-reviewed journal Neurology, will ease the minds of individuals still hesitant to be vaccinated. /articles//images/uploads/2022/08/24/6306900f47e78_1920vaccine-covid-stroke-cedars-sinai.jpg,/images/uploads/2022/08/24/630690307801f_800alexis-simpkins-md-cedars-sinai.jpg,/images/uploads/2022/08/24/63069067c7639_800nancy-sicotte-md-cedars-sinai-3.jpg Cedars-Sinai Reduced myocardial blood flow is new clue in how COVID-19 is impacting the heart /articles/reduced-myocardial-blood-flow-is-new-clue-in-how-covid-19-is-impacting-the-heart/?sc=c6547 /articles/reduced-myocardial-blood-flow-is-new-clue-in-how-covid-19-is-impacting-the-heart/?sc=c6547 Wed, 17 Aug 2022 14:45:34 EST Cardiovascular Health,Heart Disease,Infectious Diseases,Public Health,Vaccines,Coronavirus,All Journal News Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/08/17/62fd3294a1870_JACCLongCOVIDHeart.jpg&width=100&height=150" alt="Newswise image" />Patients with prior COVID may be twice as likely to have unhealthy endothelial cells that line the inside of the heart and blood vessels, according to newly published research from Houston Methodist. This finding offers a new clue in understanding COVID-19's impact on cardiovascular health. /articles//images/uploads/2022/08/17/62fd3294a1870_JACCLongCOVIDHeart.jpg Houston Methodist Coronavirus Jumped to Humans at Least Twice at Market in Wuhan, China /articles/coronavirus-jumped-to-humans-at-least-twice-at-market-in-wuhan-china/?sc=c6547 /articles/coronavirus-jumped-to-humans-at-least-twice-at-market-in-wuhan-china/?sc=c6547 Tue, 26 Jul 2022 10:05:10 EST All Journal News,Infectious Diseases,Public Health,Coronavirus,China,U.S. Politics,Staff Picks Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/07/26/62dff8f0ea88c_20220726fusion-medical-animation-rnr8D3FNUNY-unsplash.jpg&width=100&height=150" alt="Newswise image" />In a pair of related studies, UC San Diego researchers show that the origin of the COVID-19 pandemic was at a Chinese market and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there. /articles//images/uploads/2022/07/26/62dff8f0ea88c_20220726fusion-medical-animation-rnr8D3FNUNY-unsplash.jpg,/images/uploads/2022/07/26/62dff960d78b0_20220726joelwertheim.jpg,/images/uploads/2022/07/26/62dff97783f1a_20220726niemamoshiri.jpg UC San Diego Health Scientists Trace Earliest Cases of COVID-19 to Market in Wuhan, China /articles/scientists-trace-earliest-cases-of-covid-19-to-market-in-wuhan-china/?sc=c6547 /articles/scientists-trace-earliest-cases-of-covid-19-to-market-in-wuhan-china/?sc=c6547 Tue, 26 Jul 2022 10:00:00 EST All Journal News,Infectious Diseases,Public Health,Coronavirus,China Medical News Research Results An international team of 18 researchers have determined that the earliest cases of COVID-19 in humans arose at a wholesale fish market in Wuhan China in December, 2019. They linked these cases to bats, foxes and other live mammals infected with the virus sold in the market either for consumption as meat or for their fur. University of Utah Health Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses, finds study of over 7 million adults /articles/pfizer-biontech-and-astrazeneca-vaccines-offer-high-protection-against-severe-covid-19-6-months-after-second-doses-finds-study-of-over-7-million-adults/?sc=c6547 /articles/pfizer-biontech-and-astrazeneca-vaccines-offer-high-protection-against-severe-covid-19-6-months-after-second-doses-finds-study-of-over-7-million-adults/?sc=c6547 Wed, 20 Jul 2022 18:30:00 EST Healthcare,Immunology,Infectious Diseases,Public Health,Vaccines,Coronavirus,Pharmaceuticals,All Journal News Medical News Research Results Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [July 20], found protection in older adults aged over 65 years, and in clinically vulnerable adults. University of Bristol Mask Wearing Amplifies Harms of Smoking /articles/mask-wearing-amplifies-harms-of-smoking/?sc=c6547 /articles/mask-wearing-amplifies-harms-of-smoking/?sc=c6547 Fri, 08 Jul 2022 15:05:30 EST All Journal News,Cardiovascular Health,Heart Disease,Smoking,Coronavirus,Staff Picks Medical News Research Results Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold rise in exhaled carbon monoxide and impaired blood vessel function compared to non-mask periods. European Society of Cardiology COVID-19 Vaccination in Pregnancy Helps Protect Infants from Needing Hospital Care for COVID-19 /articles/covid-19-vaccination-in-pregnancy-helps-protect-infants-from-needing-hospital-care-for-covid-19/?sc=c6547 /articles/covid-19-vaccination-in-pregnancy-helps-protect-infants-from-needing-hospital-care-for-covid-19/?sc=c6547 Fri, 24 Jun 2022 11:05:57 EST All Journal News,Immunology,OBGYN,Vaccines,Coronavirus,Staff Picks,NEJM Medical News Research Results In a new study sponsored by the Centers for Disease Control and Prevention and published in the New England Journal of Medicine, researchers provide additional evidence that COVID-19 vaccination during pregnancy helps protect babies younger than 6 months from being hospitalized due to COVID-19. The risk of COVID-19 hospitalization among babies was reduced by about 80 percent during the Delta wave (July 1-December 18, 2021) and 40 percent during the Omicron wave (December 19-March 8, 2022). Ann and Robert H. Lurie Children's Hospital of Chicago Exercise after flu shot, COVID-19 vaccine bumps up antibodies /articles/exercise-after-flu-shot-covid-19-vaccine-bumps-up-antibodies/?sc=c6547 /articles/exercise-after-flu-shot-covid-19-vaccine-bumps-up-antibodies/?sc=c6547 Fri, 11 Feb 2022 12:00:51 EST All Journal News,Exercise and Fitness,Immunology,Vaccines,Coronavirus,Staff Picks Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/02/11/6206929143bbb_20151013fall_walk1.JPG&width=100&height=150" alt="Newswise image" />Participants in the study who cycled on a stationary bike or took a brisk walk for an hour-and-a-half after getting a flu shot or COVID-19 jab produced more antibodies in the following four weeks compared to participants who sat or continued with their daily routine post-immunization. /articles//images/uploads/2022/02/11/6206929143bbb_20151013fall_walk1.JPG Iowa State University Current vaccines teach T cells to fight Omicron /articles/current-vaccines-teach-t-cells-to-fight-omicron/?sc=c6547 /articles/current-vaccines-teach-t-cells-to-fight-omicron/?sc=c6547 Mon, 24 Jan 2022 11:55:14 EST All Journal News,Immunology,Infectious Diseases,Vaccines,Coronavirus,Grant Funded News,Staff Picks Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2022/01/24/61eed61beb4b8_Grifoni_small.png&width=100&height=150" alt="Newswise image" />Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2. These T cells can recognize SARS-CoV-2 Variants of Concern, including Delta and Omicron. /articles//images/uploads/2022/01/24/61eed61beb4b8_Grifoni_small.png La Jolla Institute for Immunology International Study Identifies Predictors of Severe Outcomes in Children with COVID-19 /articles/international-study-identifies-predictors-of-severe-outcomes-in-children-with-covid-19/?sc=c6547 /articles/international-study-identifies-predictors-of-severe-outcomes-in-children-with-covid-19/?sc=c6547 Wed, 12 Jan 2022 15:05:33 EST All Journal News,Children's Health,Emergency Medicine,Infectious Diseases,Coronavirus,JAMA,Staff Picks Medical News Research Results A new international study offers a clearer picture of the impact of COVID-19 infection and the risk of severe outcomes on young people around the world. Ann and Robert H. Lurie Children's Hospital of Chicago Weathering the Omicron Surge, Explaining "Flurona" /articles/weathering-the-omicron-surge-explaining-flurona/?sc=c6547 /articles/weathering-the-omicron-surge-explaining-flurona/?sc=c6547 Wed, 05 Jan 2022 15:30:02 EST Cardiovascular Health,Children's Health,Infectious Diseases,Vaccines,Coronavirus,Staff Picks Medical News Feature Expert First on the list: Get vaccinated and get a booster shot if you qualify. Cedars-Sinai